serodiagnosi
human
helminth
infect
mani
current
use
test
reli
nativ
antigen
either
extract
whole
worm
somat
antigen
maintain
laboratori
anim
cultiv
vitro
obtain
excretorysecretori
product
metabol
antigen
natur
antigen
limit
avail
suffer
batchtobatch
variat
number
echinococcu
protein
recombinantli
produc
test
use
serodiagnosi
knowledg
recombin
relat
sequenc
success
appli
commerci
test
kit
recombinantli
express
antigen
use
diagnost
test
requir
high
degre
purif
avoid
crossreact
due
contamin
express
system
unspecif
bind
crossreact
major
problem
extract
whole
worm
recombin
protein
improv
diagnost
test
perform
desir
identifi
highli
specif
highli
reactiv
epitop
proteom
pathogen
question
synthet
produc
correspond
peptid
antigen
synthet
peptid
advantag
diagnost
applic
sinc
well
defin
easili
produc
larg
amount
highli
pure
often
costsav
compar
product
natur
antigen
anim
model
vitro
cultur
applic
peptid
immunodiagnosi
differ
parasit
diseas
given
noya
et
al
avail
increas
number
pathogen
genom
boost
basic
research
well
appli
scienc
field
parasitolog
diagnost
sequenc
parasit
genom
also
creat
new
opportun
annot
genom
proteom
avail
medic
import
protozoan
pathogen
plasmodium
speci
kinetoplastida
speci
follow
genom
parasit
nematod
brugia
malayi
genom
schistosoma
mansoni
blood
vessel
dwell
trematod
recent
releas
well
draft
genom
sequenc
schistosoma
japonicum
genom
data
variou
helminth
speci
expect
near
futur
see
exampl
http
wwwsangeracukprojectshelminth
http
wwwnematodenet
current
protein
predict
est
whole
genom
contig
avail
data
mine
alreadi
consider
number
helminth
speci
use
sequenc
data
avail
public
domain
design
test
pathway
identifi
novel
antigen
serodiagnost
test
develop
select
procedur
peptid
antigen
reli
applic
bioinformat
filter
collect
protein
sequenc
includ
conceptu
translat
nucleotid
sequenc
data
select
criteria
aim
protein
locat
hostparasit
interfac
protein
potenti
seen
host
immun
system
may
elicit
immun
respons
thu
repres
good
candid
diagnost
antigen
silico
analysi
therefor
priorit
protein
contain
sort
signal
direct
protein
extracellular
space
psort
ii
transmembran
domain
tmhmm
ii
ctermin
signatur
sequenc
addit
glycosyl
phosphatidylinositol
gpi
anchor
gpisom
predict
algorithm
requir
full
length
amino
acid
sequenc
complet
n
ctermini
thu
exclud
use
est
librari
major
protein
gener
display
well
defin
three
dimension
structur
mostli
globular
select
procedur
prefer
sequenc
chemic
synthes
peptid
also
adopt
natur
conform
vitro
two
structur
motif
meet
claim
firstli
intrins
unstructur
region
iur
lack
well
defin
three
dimension
structur
display
extend
conform
identifi
exampl
iupr
secondli
alphahel
coiledcoil
motif
predict
exampl
alphahel
coiledcoil
believ
readili
fold
stabl
structur
aqueou
solut
microarray
platform
serv
test
diagnost
potenti
peptid
select
silico
use
highthroughput
microarray
format
bring
togeth
advantag
low
reagent
consumpt
rapid
multiplex
analysi
particularli
diagnost
possibl
test
reactiv
given
serum
sampl
multipl
antigen
simultan
harbor
great
benefit
promis
candid
identifi
microarray
explor
valid
use
elisa
carri
proofofprincipl
bioinformat
select
suitabl
long
synthet
peptid
lsp
tapeworm
echinococcu
multiloculari
echinococcu
granulosu
major
medic
import
caus
alveolar
ae
cystic
echinococcosi
ce
respect
ce
particularli
ae
due
infiltr
andor
spaceoccupi
growth
sever
diseas
high
fatal
rate
poor
prognosi
manag
incorrectli
import
alveolar
echinococcosi
repres
number
report
case
rather
sever
diseas
individu
patient
standard
diagnost
test
human
echinococcosi
ae
well
ce
impli
imag
techniqu
ultrasonographi
xray
comput
tomographi
well
serolog
test
base
enzymelink
immunosorb
assay
elisa
immunoblot
antigen
use
serodiagnost
test
develop
crude
extract
purifi
fraction
recombin
antigen
e
multiloculari
vesicular
fluid
origin
vitro
cultiv
metacestod
despit
substanti
improv
achiev
main
screen
test
still
reli
avail
qualiti
nativ
antigen
ie
hydatid
fluid
echinococcu
granulosu
cyst
collect
natur
infect
intermedi
host
slaughterhous
one
studi
report
sourc
qualiti
fertil
cyst
critic
test
outcom
call
standard
antigen
test
method
produc
robust
reproduc
test
routin
diagnost
laboratori
evalu
perform
chemic
synthes
peptid
comparison
natur
eghf
recombin
antigen
ethic
clearanc
retrospect
use
anonym
patient
sera
test
develop
qualiti
control
obtain
ethic
committe
ethikkommiss
beider
basel
sera
healthi
blood
donor
live
switzerland
use
defin
cutoff
distinguish
posit
neg
test
result
elisa
blood
donor
sera
use
microarray
singl
serum
pool
made
sera
use
test
diagnost
peptid
reactiv
elisa
sera
e
multiloculari
sera
e
granulosusinfect
patient
central
europ
use
echinococcosi
patient
activ
hepat
lesion
either
type
whoiwg
standard
classif
sera
sampl
prior
therapeut
intervent
ie
surgeri
andor
chemotherapi
diagnos
confirm
serolog
describ
et
al
complement
clinic
diagnosi
base
imag
procedur
avail
retrospect
histopatholog
investig
test
crossreact
peptid
sera
patient
follow
infect
use
concomit
echinococcosi
rule
clinic
serolog
criteria
trichinellosi
trichuriasi
toxocariasi
ascariasi
anisakiasi
hookworm
infect
strongyloidiasi
filariasi
loa
loa
mansonella
perstan
onchocerca
volvulu
fascioliasi
paragonimiasi
schistosomiasi
schistosoma
mansoni
haematobium
mekongi
neurocysticercosi
taenia
solium
taeniasi
taenia
saginata
diphyllobothriasi
amoeb
liver
abscess
entamoeba
histolytica
protein
sequenc
echinococcu
multiloculari
e
granulosu
retriev
ncbi
entrez
protein
databas
octob
ncbi
entrez
protein
databas
compil
varieti
sourc
daili
updat
includ
swissprot
pir
prf
pdb
translat
annot
code
region
genbank
refseq
identifi
put
membran
extracellular
protein
protein
sequenc
analyz
use
tmhmm
ii
predict
transmembran
domain
gpisom
predict
glycosylphosphatidylinisotol
gpi
anchor
signal
psort
ii
predict
protein
subcellular
local
protein
sequenc
screen
stretch
alphahel
coiledcoil
use
intrins
unstructur
region
use
iupr
structur
believ
adopt
nativ
conform
aqueou
solut
therefor
constitut
major
select
criteria
due
limit
number
echinococcu
sequenc
ncbi
entrez
protein
databas
predict
surfac
protein
contain
stretch
alphahel
cc
andor
iur
analysi
extend
protein
alphahel
coiledcoil
iur
predict
irrespect
predict
locat
includ
known
protein
previous
test
immunodiagnosi
narrow
protein
region
select
peptid
protein
sequenc
subject
predict
coiledcoil
stabil
stablecoil
http
biomoluchsceducoresbiophysicsstablecoil
case
iur
antigen
predict
perform
use
bepipr
thu
detect
region
high
predict
cc
stabil
antigen
favor
increas
solubl
peptid
select
start
end
hydrophil
neutral
amino
acid
harbour
averag
one
charg
amino
acid
either
posit
neg
per
five
residu
addit
guidelin
suggest
manufactur
follow
http
wwwaltabiosciencebhamacukpdfsintrotoseriessyntheticpeptidespdf
sequenc
list
tabl
peptid
select
accord
criteria
mention
peptid
produc
fmoc
solid
phase
synthesi
alta
bioscienc
univers
birmingham
uk
length
peptid
limit
episcan
synthesi
procedur
alta
bioscienc
univers
birmingham
uk
maximum
amino
acid
thu
length
peptid
use
spot
onto
microarray
rang
amino
acid
addit
aminohexanoid
acid
ahx
spacer
biotin
nterminu
biotin
requir
bind
peptid
streptavidinco
solid
phase
ie
microscop
glass
slide
microarray
alta
bioscienc
univers
birmingham
uk
well
plate
elisa
order
remov
electr
charg
free
cterminu
synthet
peptid
modifi
carboxytermin
amid
thu
ntermin
ctermin
peptid
end
uncharg
mimick
natur
segment
intern
protein
sequenc
defin
optim
peptid
length
design
extend
variant
reactiv
candid
microarray
length
extend
peptid
rang
residu
tabl
modif
n
cterminu
ident
microarray
peptid
extens
peptid
chosen
increas
alphahel
coiledcoil
stabil
combin
epitop
two
singl
peptid
target
improv
peptid
e
multiloculari
diagnosi
chose
e
multiloculari
sequenc
design
longer
peptid
sequenc
deriv
antigen
access
number
antigen
access
number
knowledg
first
synthet
peptid
e
multiloculari
antigen
b
sequenc
serolog
evalu
align
homolog
antigen
antigen
two
echinococcu
speci
shown
figur
respect
antigen
e
granulosu
e
multiloculari
show
ident
antigen
ident
peptid
coincid
region
previous
publish
e
granulosu
epitop
evkyff
differ
anoth
publish
synthet
peptid
span
ntermin
region
antigen
amino
acid
cover
central
part
protein
amino
acid
within
overlap
amino
acid
three
amino
acid
differ
microarray
platform
use
screen
silico
select
peptid
reactiv
patient
sera
lowdens
peptid
microarray
alta
bioscienc
univers
birmingham
uk
featur
two
block
contain
echinococcu
peptid
spot
spot
control
allow
posit
grid
analysi
unrel
tamralabel
peptid
control
serolog
detect
human
igg
blank
spot
solut
microarray
work
done
room
temperatur
microarray
slide
block
one
hour
assay
buffer
ph
milk
powder
individu
human
sera
serum
pool
dilut
assay
buffer
incub
two
hour
moist
chamber
slide
wash
minut
assay
buffer
incub
one
hour
dilut
goat
antihuman
igg
hl
secondari
antibodi
jackson
immunoresearch
laboratori
product
number
slide
wash
minut
assay
buffer
quickli
rins
deioniz
water
dri
compress
air
slide
scan
nm
use
genepix
microarray
scanner
bucher
biotec
ag
basel
switzerland
tamra
imag
local
background
correct
fluoresc
intens
fi
acquir
use
axon
genepix
pro
softwar
analysi
done
microsoft
excel
duplic
fivalu
averag
peptid
determin
reactiv
fi
cutoff
determin
test
singl
pool
blood
donor
sampl
pool
made
sera
calcul
averag
fi
intens
plu
time
standard
deviat
chose
standard
deviat
rather
major
duplic
valu
differ
variat
explain
unequ
spot
morpholog
peptid
reactiv
spot
forward
evalu
test
sensit
specif
perform
elisa
current
standard
format
routin
serodiagnost
plate
nunc
immobil
streptavidin
prewash
three
time
use
elisa
plate
washer
deioniz
coat
overnight
synthet
peptid
dilut
pb
ph
follow
step
carri
room
temperatur
wash
plate
block
one
hour
assay
buffer
milk
pb
ph
mm
biotin
plate
wash
incub
one
hour
human
sera
dilut
assay
buffer
alkalinephosphataseconjug
goat
antihuman
igg
antibodi
sigma
product
number
assay
buffer
use
secondari
antibodi
wash
conjug
dilut
ad
well
incub
one
hour
follow
final
wash
well
incub
minut
pnitrophenyl
phosphat
sigma
product
number
n
concentr
mg
substrat
buffer
mm
mm
ph
absorb
valu
measur
nm
tecan
sunris
micropl
absorb
reader
serum
sampl
test
duplic
two
valu
averag
blankcorrect
distinguish
posit
neg
elisa
test
result
sera
healthi
blood
donor
live
switzerland
test
cutoff
valu
determin
mean
blood
donor
sampl
plu
two
standard
deviat
sensit
specif
singl
peptid
candid
calcul
use
test
result
confirm
echinococcosi
patient
true
posit
tp
blood
donor
individu
infect
helminth
taken
true
neg
tn
work
characterist
peptid
antigen
explor
receiveroper
characterist
roc
plot
analysi
analyseit
version
test
impact
pool
peptid
candid
lsp
mix
equal
part
mixw
appli
condit
describ
cutoff
determin
mean
fifti
blood
donor
sampl
plu
standard
deviat
sensit
crossreact
behavior
test
echinococcosi
sera
sera
variou
helminth
amoeba
infect
previous
shown
crossreact
singl
peptid
entri
e
multiloculari
entri
e
granulosu
protein
retriev
ncbi
entrez
protein
databas
includ
redund
combin
output
psort
ii
tmhmm
ii
gpisom
iupr
led
select
protein
candid
tabl
accord
inform
avail
genbank
protein
isol
metacestod
protoscolex
tissu
possibl
except
inform
development
stage
provid
six
protein
report
previous
react
antibodi
patient
sera
grp
earlier
find
support
inclus
antigen
analysi
total
peptid
sequenc
protein
chosen
chemic
synthes
spot
onto
microarray
peptid
deriv
e
multiloculari
e
granulosu
tabl
silico
select
peptid
screen
diagnost
potenti
microarray
platform
alta
bioscienc
univers
birmingham
uk
total
peptid
contain
microarray
show
reactiv
pool
singl
sera
echinococcosi
patient
peptid
e
multiloculari
peptid
e
granulosu
peptid
react
cutoff
determin
blood
donor
sera
fi
list
tabl
peptid
consid
diagnost
potenti
therefor
subject
test
specif
sensit
predict
structur
reactiv
peptid
candid
mostli
alphahel
coiledcoil
peptid
alphahel
peptid
peptid
predict
intrins
unstructur
peptid
reactiv
microarray
carri
forward
evalu
applic
elisabas
serodiagnosi
current
routin
techniqu
test
sera
ae
ce
patient
sera
patient
infect
echinococcosi
use
sensit
crossreact
impact
peptid
length
evalu
data
shown
respect
sensit
long
peptid
residu
superior
shorter
one
peptid
select
extens
valid
deriv
e
multiloculari
e
multiloculari
antigen
peptid
clearli
differenti
ae
ce
infect
seen
overlap
standard
deviat
valu
obtain
ae
ce
sera
figur
peptid
deriv
well
establish
antigen
specif
diagnosi
e
multiloculari
infect
hand
react
ae
ce
sera
tabl
ae
ce
contrast
previou
observ
specif
reactiv
ae
sera
reactiv
peptid
similar
ae
ce
peptid
e
multiloculari
antigen
react
ce
ae
sera
ae
ce
tabl
cutoff
valu
determin
blood
donor
similar
respect
cutoff
higher
od
compar
sensit
commerci
e
granulosu
hydatid
fluid
elisa
use
routin
test
sensit
singl
peptid
alon
rather
low
candid
sensit
reach
specif
respect
thu
perform
rang
requir
routin
diagnost
assay
minor
crossreact
observ
sera
helminth
infect
echinococcosi
tabl
peptid
posit
cysticercosi
strongyloidiasi
schistosomiasi
sera
peptid
seroposit
strongyloidiasi
toxocariasi
filariasi
fascioliasi
schistosomiasi
sera
peptid
posit
strongyloidiasi
toxocariasi
schistosomiasi
sera
crossreact
taenia
strongyloid
filaria
also
seen
convent
diagnost
assay
test
specif
sera
patient
suffer
liver
abscess
due
entamoeba
histolytica
infect
posit
amebiasi
sera
tabl
compar
diagnost
perform
peptid
receiveroper
characterist
roc
plot
gener
figur
candid
emerg
clear
favorit
although
meet
sensit
requir
antigen
appli
routin
diagnost
use
peptid
serolog
impair
sensit
compar
full
length
antigen
peptid
like
harbor
less
epitop
calcul
cumul
sensit
singl
peptid
elisa
measur
experiment
combin
peptid
one
antigen
mix
mixw
cutoff
mixw
rang
cutoff
one
compon
name
cumul
individu
result
assay
theoret
sensit
inde
increas
specif
decreas
tabl
compar
cumul
posit
pool
peptid
one
well
mixw
led
loss
posit
test
result
return
specif
increas
due
loss
crossreact
posit
test
result
obtain
singl
peptid
elisa
compar
pool
peptid
elisa
summar
tabl
use
synthet
peptid
substitut
nativ
antigen
immunoassay
highli
recommend
diagnosi
infecti
diseas
differ
author
synthet
peptid
appli
success
diagnosi
viral
bacteri
infect
compar
metazoan
parasit
virus
bacteria
gener
smaller
genom
accomplish
less
complex
post
translat
protein
modif
might
impli
rapid
success
identif
immunodomin
peptid
even
allow
analysi
whole
proteom
level
investig
use
synthet
peptid
amino
acid
length
use
immunodiagnosi
human
hydatid
diseas
provid
proof
principl
select
synthet
peptid
bioinformat
mean
screen
microarray
platform
diagnost
reactiv
peptid
microarray
proof
reactiv
sera
echinococcosi
patient
peptid
perform
best
investig
peptid
deriv
e
multiloculari
antigen
reach
sensit
specif
reactiv
lsp
sera
ae
well
ce
patient
suggest
use
patient
screen
well
followup
examin
treat
patient
latter
purpos
necessari
determin
proport
patient
seroconvert
treatment
applic
peptid
antigen
monitor
treatment
followup
sampl
ongo
work
laboratori
result
confirm
previou
report
test
base
singl
peptid
need
complement
addit
peptid
reach
sensit
compar
antigen
extract
compens
limit
sensit
individu
peptid
perform
elisa
combin
synthet
peptid
appli
mixtur
coat
compar
result
cumul
sensit
theoret
valu
obtain
sum
posit
result
individu
peptid
elisa
serum
test
cumul
result
amount
theoret
sensit
detect
high
sensit
contrast
pool
peptid
one
well
led
loss
posit
signal
otherwis
obtain
individu
test
peptid
echinococcosi
sampl
lost
pool
one
reason
suggest
increas
cutoff
pool
peptid
sera
similar
od
observ
individu
test
peptid
mixtur
due
increas
cutoff
pool
peptid
sera
turn
neg
loss
sensit
obtain
pool
peptid
mixw
could
also
due
partial
occup
streptavidin
bind
site
less
reactiv
antigen
reason
may
account
increas
specif
combin
peptid
one
well
led
loss
unwant
crossreact
previous
fals
posit
signal
disappear
thu
studi
pool
peptid
increas
specif
lower
sensit
futur
work
peptid
mix
might
optim
combin
peptid
equal
good
diagnost
sensit
specif
particular
sensit
mix
like
increas
continu
search
new
peptid
improv
diagnost
oper
characterist
substitut
least
reactiv
candid
behaviour
peptid
mixtur
appli
antigen
elisa
need
investig
select
peptid
broad
recognit
human
echinococcosi
patient
bioinformat
select
aim
export
parasit
surfac
expos
antigen
protein
like
elicit
immun
respons
major
drawback
scarc
number
fulllength
echinococcu
spp
protein
sequenc
deposit
public
databas
thu
might
worthwhil
studi
adapt
bioinformat
select
criteria
use
partial
est
sequenc
data
point
need
screen
peptid
candid
investig
whole
genom
level
like
provid
addit
candid
suffici
sensit
specif
eventu
combin
synthet
antigen
pool
singl
pool
lsp
compat
high
throughput
platform
technolog
luminex
biacor
technolog
could
replac
elisa
futur
addit
surfac
extracellular
local
one
criterion
bioinformat
select
predict
secondari
structur
alphahel
coiledcoil
intrins
unstructur
protein
believ
adopt
nativ
conform
aqueou
solut
might
therefor
well
suit
immunoassay
wide
accept
major
epitop
conform
type
result
show
diagnost
purpos
predict
alphahel
alphahel
coiledcoil
peptid
superior
peptid
deriv
intrins
unstructur
region
among
serumreact
peptid
identifi
microarray
screen
peptid
predict
alphahel
organ
peptid
deriv
intrins
unstructur
region
furthermor
extens
test
candid
iur
peptid
dismiss
due
lack
sensit
addit
secondari
tertiari
structur
peptid
determin
recognit
immobil
peptid
solid
phase
use
immunodiagnost
test
antibodi
captur
peptid
crucial
depend
access
key
residu
therefor
introduct
spacer
molecul
spatial
separ
peptid
carrier
protein
vital
import
peptid
studi
synthes
ntermin
ahxspac
coupl
biotin
biotin
use
immobil
peptid
antigen
streptavidinco
solid
phase
ie
microscop
glass
slide
elisa
plate
coat
biotinyl
peptid
nonstreptavidin
surfac
immulon
thermo
scientif
poli
sorp
nunc
elisa
plate
led
sampl
test
discrep
duplic
valu
mostli
reduc
valu
nonlinear
manner
data
shown
immobil
peptid
direct
adsorb
polystyren
surfac
might
lead
steric
blockag
key
residu
necessari
interact
antibodi
thu
decreas
valu
similarli
peptid
show
elisa
increas
test
sensit
specif
immobil
via
biotinstreptavidin
surfac
function
streptavidin
guarante
direct
highli
dens
reproduc
coat
biotinyl
peptid
antigen
shown
direct
peptid
immobil
secondari
import
long
peptid
deriv
intern
protein
sequenc
investig
interact
intern
sequenc
depend
free
n
cterminu
therefor
attach
spacer
carrier
molecul
achiev
success
termini
peptid
approach
repres
altern
peptid
select
phage
display
bioinformat
select
avoid
construct
handl
phage
display
librari
pan
procedur
import
limit
success
pan
consist
lack
select
antibodi
antibodi
purif
human
sera
requir
pure
specif
antigen
gener
yet
avail
bioinformat
approach
peptid
select
reduc
complex
lab
work
compat
screen
peptid
microarray
hand
platform
prove
highli
suitabl
investig
antigenantibodi
interact
